Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0900
-0.0010 (-1.10%)
Sep 26, 2025, 4:10 PM AEST
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 29.05 million as of September 26, 2025. Its market cap has increased by 85.46% in one year.
Market Cap
29.05M
Enterprise Value
28.67M
Revenue
3.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has decreased from 32.74M to 29.05M, a decrease of -11.29%. That is a compound annual growth rate of -1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 29.05M | 17.72% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | 176.31M | 1,246.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 95.48B |
| Pro Medicus | 32.12B |
| Cochlear | 18.92B |
| Sonic Healthcare | 10.74B |
| Ramsay Health Care | 7.50B |
| Telix Pharmaceuticals | 5.23B |
| Ansell | 4.76B |
| Mesoblast | 3.14B |